TG6050, an oncolytic vaccinia virus encoding interleukin-12 and anti-CTLA-4 antibody, favors tumor regression via profound immune remodeling of the tumor microenvironment

Article disponible en anglais ici sur le site du JITC (The Journal for ImmunoTherapy of Cancer)